Bill Status of SB 1604   100th General Assembly


Short Description:  PHARMACY-PRESCRIPTION DRUGS

Senate Sponsors
Sen. William E. Brady-Linda Holmes

Last Action  View All Actions

DateChamber Action
  1/9/2019SenateSession Sine Die

Statutes Amended In Order of Appearance
5 ILCS 80/4.28
5 ILCS 80/4.30
225 ILCS 85/25from Ch. 111, par. 4145

Synopsis As Introduced
Amends the Pharmacy Practice Act. Provides that if a physician or other authorized prescriber does not prohibit drug product substitution, a pharmacist shall dispense a brand name drug product as a substitute for an unavailable nonbrand name drug product specified in the prescription. Provides that if the substitute drug product has a unit price greater than the unavailable drug product specified in the prescription, then the pharmacist shall dispense that substitute drug product at the lesser unit price of the drug product specified in the prescription. Amends the Regulatory Sunset Act to extend the repeal date for the Pharmacy Practice Act to January 1, 2020. Makes conforming changes. Effective immediately.

Actions 
DateChamber Action
  2/9/2017SenateFiled with Secretary by Sen. Chris Nybo
  2/9/2017SenateFirst Reading
  2/9/2017SenateReferred to Assignments
  2/9/2017SenateAdded as Chief Co-Sponsor Sen. Linda Holmes
  2/28/2017SenateAssigned to Licensed Activities and Pensions
  3/17/2017SenateRule 2-10 Committee Deadline Established As April 7, 2017
  3/29/2017SenatePostponed - Licensed Activities and Pensions
  4/6/2017SenatePostponed - Licensed Activities and Pensions
  4/7/2017SenateRule 3-9(a) / Re-referred to Assignments
  11/15/2018SenateChief Sponsor Changed to Sen. William E. Brady
  1/9/2019SenateSession Sine Die

Back To Top